Physician profile
Bryan R Johnson
NPI 1922036813
$996.91
in general payments reported to CMS, 2019-2025
16 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $14.87 · 2021: $95.91 · 2022: $180 · 2023: $117 · 2024: $275 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $177.85 | 2022-2025 | Total30, Clareon, Precision 1 |
| Sun Pharmaceutical Industries INC. | $130.50 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.31 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $79.30 | 2025 | Xdemvy |
| Abbvie INC. | $72.45 | 2022-2024 | |
| Sight Sciences, INC. | $68.07 | 2023-2024 | Omni Surgical System |
| Kala Pharmaceuticals, INC. | $64.73 | 2019-2021 | |
| Biotissue Holdings INC. | $53.47 | 2022-2025 | |
| Allergan, INC. | $50.20 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $44.83 | 2019-2022 | |
| Oyster Point Pharma, INC. | $41.39 | 2022-2024 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $38.37 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $20.88 | 2024 | |
| Bausch & Lomb Americas INC. | $14.78 | 2025 | Vyzulta, Miebo |
| Dompe US, INC. | $14.31 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.